| COMPOSITION: | Each film coated tablet contains Calcium-3-methyl-2-oxo-valerate 67mg (a-Ketoanalogue to isoleucine calcium salt), Calcium-4-methyl-2-oxo-valerate 101 mg (a-Ketoanalogue to leucine calcium salt), Calcium-2-oxo-3-phenylpropionate 68 mg (a-Ketoanalogue to phenylalanine calcium salt), Calcium-3-methyl-2-oxo-butyrate 86 mg (a-Ketoanalogue to valine calcium salt), Calcium DL-2-Hydroxy-4 (methylthio) butyrate 59 mg (a-hydroxyanalogue to Methionine calcium salt), L-Lysine Acetate USP 105 mg (eq. to L-Lysine 75 mg), L-Threonine USP 53 mg, L-Tryptophan USP 23 mg, L-Histidine USP 38 mg & L-Tyrosine USP 30 mg. Total Nitrogen content per tablet 36 mg & Calcium content 1.25 mmol = 0.05 g per Tablet. |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Renloket tablets contains Alpha Ketoanalogue, a nutritional supplement indicated for improved kidney health in patients diagnosed with chronic kidney disease & those on dialysis with protein restricted diet. |
| SIDE EFFECTS: | Common side effects are Hypercalcaemia & mild GI upset. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
